Eupraxia Pharmaceuticals Stock Quote EPRX - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

2.595

Bid

1.02

Ask

2.75

Volume

1,099

2.52 Day's Range 2.7499

2.402 52 Week Range 3.55

Market Cap

92.441M

Previous Close

2.51

Open

2.7499

Last Trade

2.46

Last Trade Time

Financial Volume

$ 2,984

VWAP

2.7149

Average Volume (3m)

17,636

Shares Outstanding

35,622,553

Dividend Yield

PE Ratio

-4.37

Earnings Per Share (EPS)

-0.79

Revenue

Net Profit

-28.22M

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient be... Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient benefit by delivering targeted, long-lasting activity with fewer side effects. Its lead product candidate, EP-104IAR, is in development for the treatment of pain due to osteoarthritis of the knee. In addition, it is developing a pipeline of earlier-stage long-acting formulations. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.eupraxiapharma.com

Headquarters

Victoria, British Columbia, Can

Founded

1970

Eupraxia Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker EPRX. The last closing price for Eupraxia Pharmaceuticals was $2.51. Over the last year, Eupraxia Pharmaceuticals shares have traded in a share price range of $ 2.402 to $ 3.55.

Eupraxia Pharmaceuticals currently has 35,622,553 shares outstanding. The market capitalization of Eupraxia Pharmaceuticals is $89.41 million. Eupraxia Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.37.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Eupraxia Pharmaceuticals to Present at Controlled Release Society 2024 Annual Meeting and Expo

Eupraxia Pharmaceuticals to Present at Controlled Release Society 2024 Annual Meeting and Expo PR Newswire VICTORIA, BC, July 8, 2024 VICTORIA, BC, July 8, 2024 /PRNewswire/ - Eupraxia...

Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Exploring the Rapid Rise of Osteoarthritis" on July 9, 2024

Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Exploring the Rapid Rise of Osteoarthritis" on July 9, 2024 PR Newswire VICTORIA, BC, July 3...

Eupraxia Pharmaceuticals to Present Data from the Phase 2 SPRINGBOARD Study in Osteoarthritis of the Knee at EULAR European Congress of Rheumatology 2024

Eupraxia Pharmaceuticals to Present Data from the Phase 2 SPRINGBOARD Study in Osteoarthritis of the Knee at EULAR European Congress of Rheumatology 2024 Canada NewsWire VICTORIA, BC, June 5...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.065	-2.44360902256	2.66	2.85	2.46	3470	2.54246513	CS
4	-0.135	-4.94505494505	2.73	2.87	2.402	6022	2.58585831	CS
12	-0.195	-6.98924731183	2.79	3.19	2.402	17636	2.83338347	CS
26	-0.955	-26.9014084507	3.55	3.55	2.402	21000	2.83742652	CS
52	-0.955	-26.9014084507	3.55	3.55	2.402	21000	2.83742652	CS
156	-0.955	-26.9014084507	3.55	3.55	2.402	21000	2.83742652	CS
260	-0.955	-26.9014084507	3.55	3.55	2.402	21000	2.83742652	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DCAPUnity Wealth Partners Dynamic Capital Appreciation & Options ETF	20.10 (839.25%)	128.82k
RGCRegencell Bioscience Holdings Ltd	$ 15.15 (349.55%)	1.34M
ATPCAgape ATP Corporation	$ 0.2262 (58.18%)	107.31M
SLRXSalarius Pharmaceuticals Inc	$ 2.34 (51.95%)	60.04M
GSUNGolden Sun Health Technology Group Ltd	$ 7.46 (45.42%)	589.98k
FLYEFly E Group Inc	$ 1.1601 (-81.82%)	25.44M
RNAZTransCode Therapeutics Inc	$ 0.3035 (-61.70%)	9.78M
JAGXJaguar Health Inc	$ 1.755 (-58.90%)	15.47M
MIRAMIRA Pharmaceuticals Inc	$ 2.55 (-49.10%)	25.64M
IVPInspire Veterinary Partners Inc	$ 5.19 (-43.83%)	1.67M
SLNASelina Hospitality PLC	$ 0.026 (-29.73%)	220.18M
SPWRSunPower Corporation	$ 0.9514 (32.91%)	186.75M
NVDANVIDIA Corporation	$ 122.59 (-0.77%)	173.87M
ADILAdial Pharmaceuticals Inc	$ 1.3422 (26.62%)	160.04M
HOLOMicroCloud Hologram Inc	$ 0.588 (26.07%)	135.53M